{
    "title": "Lethal Drug Abuse Prevention Act of 1998",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Lethal Drug Abuse Prevention Act of \n1998''.\n\nSEC. 2. LETHAL DRUG ABUSE PREVENTION.\n\n    (a) Denial of Registration.--Section 303 of the Controlled \nSubstances Act (21 U.S.C. 823) is amended by adding at the end the \nfollowing:\n    ``(i) Additional Ground for Denial of Registration--Assisted \nSuicide.--The Attorney General shall determine that registration of an \napplicant under this section is inconsistent with the public interest \nif--\n            ``(1) during the 5-year period immediately preceding the \n        date on which the application is submitted under this section, \n        the registration of the applicant under this section was \n        revoked under section 304(a)(4); or\n            ``(2) the Attorney General determines, based on clear and \n        convincing evidence, that the applicant is applying for the \n        registration with the intention of using the registration to \n        take any action that would constitute a violation of section \n        304(a)(4).''.\n    (b) Suspension or Revocation of Registration.--\n            (1) In general.--Section 304(a) of the Controlled \n        Substances Act (21 U.S.C. 824(a)) is amended--\n                    (A) by redesignating paragraphs (4) and (5) as \n                paragraphs (5) and (6), respectively; and\n                    (B) by inserting after paragraph (3) the following:\n            ``(4) has intentionally dispensed or distributed a \n        controlled substance with a purpose of causing, or assisting in \n        causing, the suicide or euthanasia of any individual, except \n        that this paragraph does not apply to the dispensing or \n        distribution of a controlled substance for the purpose of \n        alleviating pain or discomfort (even if the use of the \n        controlled substance may increase the risk of death), so long \n        as the controlled substance is not also dispensed or \n        distributed for the purpose of causing, or assisting in \n        causing, the death of an individual for any reason;''.\n            (2) Conforming amendment.--Section 304(a)(5) of the \n        Controlled Substances Act (21 U.S.C. 824(a)(5)) (as \n        redesignated by paragraph (1) of this subsection) is amended by \n        inserting ``other'' after ``such'' the first place such term \n        appears.\n    (c) Pain Relief.--Section 304(c) of the Controlled Substances Act \n(21 U.S.C. 824(c)) is amended--\n            (1) by striking ``(c) Before'' and inserting the following:\n    ``(c) Procedures.--\n            ``(1) Order to show cause.--Before''; and\n            (2) by adding at the end the following:\n    ``(2) Assisted suicide.--\n            ``(A) Burden of proof.--At any proceeding under paragraph \n        (1), where the order to show cause is based on subsection \n        (a)(4) for denial, revocation, or suspension of registration, \n        the Attorney General shall have the burden of proving, by clear \n        and convincing evidence, that the practitioner's intent was to \n        dispense or distribute a controlled substance with a purpose of \n        causing, or assisting in causing, the suicide or euthanasia of \n        any individual. In meeting such burden it shall not be \n        sufficient to prove that the registrant knew that the use of \n        the controlled substance may increase the risk of death.\n            ``(B) Request for review by Medical Advisory Board on Pain \n        Relief.--At any proceeding under paragraph (1), where the order \n        to show cause is based on subsection (a)(4) for denial, \n        revocation, or suspension of registration, the practitioner may \n        request, within 30 days after the receipt of the order to show \n        cause, that the Medical Advisory Board on Pain Relief review, \n        in accordance with paragraph (3), the administrative record of \n        such proceeding as it relates to subsection (a)(4).\n    ``(3) Medical advisory board on pain relief.--\n            ``(A) In general.--The Attorney General shall by regulation \n        establish a board to be known as the Medical Advisory Board on \n        Pain Relief (referred to in this paragraph as the `Board').\n            ``(B) Membership.--The Attorney General shall appoint the \n        members of the Board--\n                    ``(i) from among individuals who, by reason of \n                specialized education or substantial relevant \n                experience in pain management, are clinical experts \n                with knowledge regarding standards, practices, and \n                guidelines concerning pain relief; and\n                    ``(ii) after consultation with the American Medical \n                Association, the American Academy of Pain Medicine, the \n                American Pain Society, the American Academy of Hospice \n                and Palliative Medicine, the National Hospice \n                Organization, the American Geriatrics Society, and such \n                other entities with relevant expertise concerning pain \n                relief, as the Attorney General determines to be \n                appropriate.\n            ``(C) Duties of Board.--If in accordance with paragraph \n        (2)(B) an applicant or registrant requests a review by the \n        Board of the record of a proceeding under paragraph (1), the \n        Board shall review the administrative record of such proceeding \n        as it relates to subsection (a)(4) and issue to the Attorney \n        General an advisory opinion as to whether the dispensing or \n        distribution of the controlled substance at issue in the \n        proceeding was for the purpose of alleviating pain or \n        discomfort in a manner that does not constitute a violation of \n        subsection (a)(4). The opinion of the Board under this \n        subparagraph shall be part of the administrative record and \n        shall be considered by the Attorney General in determining \n        whether to deny, revoke, or suspend the registration \n        involved.''.\n\nSEC. 3. CONSTRUCTION.\n\n    (a) In General.--Nothing in this Act or the amendments made by this \nAct shall be construed to imply that the dispensing or distribution of \na controlled substance before the date of enactment of this Act for the \npurpose of causing, or assisting in causing, the suicide or euthanasia \nof any individual is or is not a violation of the Controlled Substances \nAct (21 U.S.C. 801 et seq.).\n    (b) Incorporated Definitions.--In this section, the terms \n``controlled substance'', ``dispense'', and ``distribute'' have the \nmeanings given those terms in section 102 of the Controlled Substances \nAct (21 U.S.C. 802).\n                                     \n\n\n\n\n\n105th CONGRESS\n\n  2d Session\n\n                               H. R. 4006\n\n                      [Report No. 105-683, Part I]\n\n_______________________________________________________________________\n\n                                 A BILL\n\nTo clarify Federal law to prohibit the dispensing or distribution of a \n   controlled substance for the purpose of causing, or assisting in \n         causing, the suicide or euthanasia of any individual."
}